This approach uses mesenchymal stem cells isolated from a patient’s own fat tissue to treat neurodegenerative diseases. The stem cells are supposed to assist in repair of damaged tissue and ...
A first in-human, phase I trial examined feasibility as well as safety ...
Mesenchymal stem cells (MSCs) are unique adult stem cells with immunosuppressive properties that also may play a key role in preventing autoimmunity. In a new study, researchers identified metabolic ...
A phase 1 clinical trial published in The Lancet has shown that combining stem cell therapy with standard fetal surgery before birth is a safe and promising approach to treat myelomeningocele, a ...